KZA kazia therapeutics limited

Ann: Preliminary update from ongoing Phase 2 Study of Paxalisib, page-3

  1. 1,721 Posts.
    lightbulb Created with Sketch. 541
    Not surprised. We finally get a trail update and it's a fizzer.

    2 and a half years and only half way through a 25 patient trial. At this rate we could expect final results sometime in 2026.

    Results so far underwhelming and investigator having to lower the starting dose due to tolerability issues.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.